We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

XAIR:NASDAQBeyond Air, Inc. Analysis

Data as of 2026-09-01 - not real-time

$3.97

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Beyond Air, Inc. is bearish at $3.97, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 33.6%. Momentum indicators put RSI at 34.1 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at $3.85 and resistance at $7.23.
The shares look undervalued, trading on 0.0 times earnings below a sector average of 30.4. Consensus targets land 655.7% above where the shares trade now.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 132.0%, a beta of 0.54 and a maximum drawdown of 94.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

FDA approval decision looms for next-gen device as revenue guidance projects 110% growth.Beyond Air Inc XAIR reports flat Q1 revenue but secures $30 million financing, expands global reach, and reaffirms...$10.2 million upfront with up to $10.0 million of short-term warrants, accelerated upon FDA clearance; financing also...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 14.66
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 0.0 versus sector average of 30.4
  • Trading below the 200-day average of 14.66

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 0.0 versus sector average of 30.4
  • Analyst targets imply +655.7% versus the current price
  • Negative return on equity of -519.5%

Key Metrics & Analysis

Financial Health

Revenue Growth0.50%
P/E Ratio0.0
ROE-519.51%
ROA-57.45%
Debt/Equity831.21
P/B Ratio0.4
Op. Cash Flow$-18564000
Free Cash Flow$-14071250
Industry P/E30.4

Technical Analysis

TrendBearish
RSI34.1
Support$3.85
Resistance$7.23
MA 20$5.45
MA 50$6.55
MA 200$14.66
MACDBearish
VolumeIncreasing
Fear & Greed Index93.07

Valuation

Target Price$30.00
Upside/Downside655.67%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.54
Volatility132.02%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.